FDAnews
www.fdanews.com/articles/122422-jury-sides-with-novartis-in-generic-famvir-patent-case

Jury Sides With Novartis in Generic Famvir Patent Case

November 23, 2009
Novartis has won a patent dispute in a district court with Teva Pharmaceutical Industries over the antiviral drug Famvir, which could make Teva liable for damages due to its short-lived at-risk 2007 launch of a generic version. A jury in the U.S. District Court for the District of New Jersey decided that Novartis’ patent on Famvir (famciclovir) was not invalid based on obviousness and that the drugmaker did not withhold or misrepresent information to the PTO, according to court documents filed last week.
Drug Industry Daily